Barcelona snapshots

Prof. Christoph Correll

Christoph Correll psiquiatra Controversies Psiquiatria Barcelona
Hofstra Universtiy, EUA & Charité-Universitätsmedizin Berlin, Alemanya
Ponència Prevenció de la psicosi en nens i adolescents
Data Divendres, 17 de Setembre, 2021
Hora 15:30 - 16:15
Taula rodona 4. Trastorns psicòtics


Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York. Since 1997, he has been working and conducting research in New York, USA, and since 2017 he is also working in Germany again.

Prof. Correll's research and clinical work focus on the identification, characterization and treatment of youth and adults with severe mental illness, including psychotic and mood disorders. He further focuses on psychopharmacology, epidemiology, clinical trials, meta-analyses, the risk–benefit evaluation of psychotropic medications, and the interface between physical and mental health.

He has authored over 650 journal articles, served on several expert consensus panels, and received over 40 research awards for his work.

Since 2014, the year of inception of this metric, he has been listed every year by Clarivate/Web of Science as one of the "most influential scientific minds" and "top 1% cited scientists in the area of psychiatry".

Additionally, he has been holding numerous Expertscape rankings, such as 15 topics ranked as "Expert" (among the top 1% cited scientists), and 24 topics ranked as "World Expert" (among the top 0.1% cited scientists), including in March 2021 for example ranked as the #1 expert for:
  1. Central nervous system agents, out of 308,311 scientists (
  2. Psychotropic drugs, out of 131,808 scientists (
  3. Schizophrenia Spectrum and Other Psychotic Disorders, out of 94,268 scientists (
  4. Schizophrenia, out of 90,874 scientists (
  5. Tranquilizing agents, out of 71,122 scientists ( agents)
  6. Weight gain, out of 68,578 scientists (
  7. Delayed-action preparations out of 68,517 ranked scientists (
  8. Antipsychotics, out of 60,313 scientists (